Fundraising Fox

Athenex

Buffalo, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

FB
Flint BeseckerExecutive
LS
Li ShenExecutive
SP
Simon PedderExecutive
JL
Johnson LauExecutive
WZ
William ZuoExecutive
RK
Rudolf KwanExecutive
JY
Jeffrey YordonExecutive
JH
James HusseyExecutive

Board

AL
Antony LeungBoard director
KC
Kim CampbellBoard director
MF
Manson FokBoard director
JW
Jinn WuBoard director

Investors · 2

Avoro Capital AdvisorsNew York
Salica InvestmentsLondon

Reported raises · per SEC filings

Form D private placements

$352.7M disclosed across 7 rounds · 2015–2019

▶$60.4MraisedDec 2019 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Johnson LauExecutive Officer, Director
  • Randoll SzeExecutive Officer
  • Jeffrey YordonExecutive Officer
  • Rudolf KwanExecutive Officer
  • Simon PedderExecutive Officer
  • Jinn WuDirector
  • John VierlingDirector
  • Benson TsangDirector
  • John KohDirector
  • Jordan KanferDirector
  • Manson FokDirector
  • Stephanie DavisDirector
  • William ZuoExecutive Officer
  • Kim CampbellDirector
Offering amount
$60.4M
Amount sold
$60.4M
Sales commissions
$1M
Placement agents
SunTrust Robinson Humphrey, Inc.
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100MraisedMay 2019 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Manson FokDirector
  • Jordan KanferDirector
  • John KohDirector
  • Benson TsangDirector
  • John VierlingDirector
  • Jinn WuDirector
  • Johnson LauExecutive Officer, Director
  • Randoll SzeExecutive Officer
  • Jeffrey YordonExecutive Officer
  • Rudolf KwanExecutive Officer
  • Simon PedderExecutive Officer
  • William ZuoExecutive Officer
  • Kim CampbellDirector
  • Stephanie DavisDirector
Offering amount
$100M
Amount sold
$100M
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedJul 2018 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Manson FokDirector
  • SongYi ZhangDirector
  • Simon PedderExecutive Officer
  • Li ShenExecutive Officer
  • Jeffrey YordonExecutive Officer
  • Benson Kwan Hung TsangDirector
  • Rudolf KwanExecutive Officer
  • Jinn WuDirector
  • William ZuoExecutive Officer
  • Johnson LauExecutive Officer
  • Kim CampbellDirector
  • Sheldon Trainor-DegirolamoDirector
Offering amount
$50M
Amount sold
$50M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedMay 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Manson FokDirector
  • Jeffrey YordonExecutive Officer
  • Song-Yi ZhangDirector
  • Nick RiehleExecutive Officer
  • Rudolph KwanExecutive Officer
  • Johnson LauExecutive Officer, Director
  • Simon PedderExecutive Officer
  • William ZuoExecutive Officer
  • Jinn WuDirector
  • Antony LeungDirector
  • Kim CampbellDirector
Offering amount
$20M
Amount sold
$20M
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37.9MraisedOct 2016 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Flint BeseckerExecutive Officer, Director
  • Li ShenExecutive Officer
  • Simon PedderExecutive Officer
  • Johnson LauExecutive Officer, Director
  • William ZuoExecutive Officer
  • Kim CampbellDirector
  • Rudolf KwanExecutive Officer
  • Manson FokDirector
  • Jinn WuDirector
  • Antony LeungDirector
  • Jeffrey YordonExecutive Officer
  • James HusseyExecutive Officer
  • Song-Yi ZhangDirector
Offering amount
$50M
Amount sold
$37.9M
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedJun 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Johnson LauExecutive Officer, Director
  • Jinn WuDirector
  • Flint BeseckerExecutive Officer, Director
Offering amount
$10M
Amount sold
$10M
First sale
Apr 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$74.4MraisedJun 2015 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Flint BeseckerExecutive Officer, Director
  • Johnson LauExecutive Officer, Director
  • Jinn WuDirector
Amount sold
$74.4M
First sale
Mar 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Athenex raises $100 million in a private placement with three institutional investors | NASDAQ:ATNXproactiveinvestors.com · May 2019Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisorsglobenewswire.com · Jul 2018Buy Athenex Stock – ATNX Stock Quote Today & Investment Insights - Public.compublic.com

Frequently asked questions

Who are Athenex's investors?
Athenex's investors include Avoro Capital Advisors, Salica Investments.
How much funding has Athenex raised?
Athenex has disclosed $352.7M raised across 7 rounds.
Where is Athenex headquartered?
Athenex is headquartered in Buffalo, US.